| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog. This compound is undergoing investigation for its potential to address anxiety and the cognitive impairments frequently observed in adult patients suffering from early-stage dementia. The firm's lead candidate, MIRA1a, is a synthetic cannabinoid analog engineered to alleviate both anxiety and chronic pain through …
Over the last 12 months, insiders at MIRA Pharmaceuticals, Inc. have bought $0 and sold $0 worth of MIRA Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at MIRA Pharmaceuticals, Inc. have bought $8,176 and sold $262,825 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 8,700 shares for transaction amount of $8,176 was made by Aminov Erez (Chief Executive Officer) on 2024‑05‑21.
| 2024-11-20 | Sale | Aminov Erez | Chief Executive Officer | 44,590 0.2651% | $1.27 | $56,629 | 0.00% | |
| 2024-11-19 | Sale | Aminov Erez | Chief Executive Officer | 55,410 0.3605% | $1.39 | $77,020 | -10.00% | |
| 2024-08-28 | Sale | McNulty Brian Patrick | 10 percent owner | 200,000 1.8349% | $1.96 | $392,000 | -29.65% | |
| 2024-05-21 | Aminov Erez | Chief Executive Officer | 8,700 0.0383% | $0.94 | $8,176 | +13.73% |
| Aminov Erez | Chief Executive Officer | 1061200 2.5253% | $549,489.36 | 1 | 2 | +13.73% |
$1,927,310,793 | 31 | 28.02% | $1,325.87B | |
$364,368,632 | 29 | 9.65% | $36.8B | |
$6,224,380 | 25 | 3.58% | $640.75B | |
$23,541,811 | 22 | 6.43% | $126.14B | |
$28,542,809 | 19 | 26.39% | $505.4B |
| Increased Positions | 10 | +34.48% | 963,673 | +69.07% |
| Decreased Positions | 8 | -27.59% | 142,375 | -10.2% |
| New Positions | 2 | New | 332,777 | New |
| Sold Out Positions | 6 | Sold Out | 108,697 | Sold Out |
| Total Postitions | 31 | +6.9% | 2M | +58.87% |
| Cross Staff Investments Inc | $536.00 | 0.86% | 359,401 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $303.00 | 0.49% | 203,643 | +85,819 | +72.84% | 2025-09-30 |
| Geode Capital Management, Llc | $203.00 | 0.33% | 136,440 | +1,145 | +0.85% | 2025-09-30 |
| Blackrock, Inc. | $164.00 | 0.26% | 109,769 | +109,769 | New | 2025-09-30 |
| Suncoast Equity Management | $154.00 | 0.25% | 103,289 | 0 | 0% | 2025-09-30 |
| First American Bank | $75.00 | 0.12% | 50,000 | +30,000 | +150% | 2025-09-30 |
| State Street Corp | $73.00 | 0.12% | 49,100 | 0 | 0% | 2025-09-30 |
| Renaissance Technologies Llc | $70.00 | 0.11% | 46,700 | +46,700 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $68.00 | 0.11% | 45,703 | +25,816 | +129.81% | 2025-09-30 |
| J.W. Cole Advisors, Inc. | $68.00 | 0.11% | 45,501 | +4,846 | +11.92% | 2025-09-30 |